Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
52.94
-0.01 (-0.02%)
At close: Apr 28, 2026, 4:00 PM EDT
52.86
-0.08 (-0.15%)
After-hours: Apr 28, 2026, 5:42 PM EDT
Terns Pharmaceuticals Market Cap
Terns Pharmaceuticals has a market cap or net worth of $6.11 billion as of April 28, 2026. Its market cap has increased by 3,171.85% in one year.
Market Cap
6.11B
Enterprise Value
5.09B
1-Year Change
3,171.85%
Ranking
Category
Stock Price
$52.94
Market Cap Chart
Since the IPO on February 5, 2021, Terns Pharmaceuticals's market cap has increased from $143.61M to $6.11B, an increase of 4,156.21%. That is a compound annual growth rate of 105.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 6.11B | 39.13% |
| Dec 31, 2025 | 4.39B | 833.82% |
| Dec 31, 2024 | 470.56M | 17.33% |
| Dec 29, 2023 | 401.05M | -20.44% |
| Dec 30, 2022 | 504.08M | 182.17% |
| Dec 31, 2021 | 178.64M | 24.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Apogee Therapeutics | 6.47B |
| Protagonist Therapeutics | 6.40B |
| Celcuity | 6.20B |
| Spyre Therapeutics | 6.20B |
| Centessa Pharmaceuticals | 6.11B |
| Rhythm Pharmaceuticals | 5.93B |
| Erasca | 5.92B |
| Cogent Biosciences | 5.91B |